AVENIO Millisect

Device ROCHE SEQUENCING SOLUTIONS, INC.
Total Payments
$739,409
Transactions
18
Doctors
5
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2023 $157,601 3 1
2022 $353,658 5 0
2021 $228,151 10 4

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $727,809 11 98.4%
Consulting Fee $10,000 5 1.4%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,500 1 0.2%
Food and Beverage $100.73 1 0.0%

Payments by Type

Research
$727,809
11 transactions
General
$11,601
7 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
RD005888 ROCHE SEQUENCING SOLUTIONS, INC. $244,601 0
RD003752 ROCHE SEQUENCING SOLUTIONS, INC. $168,399 0
RD005152 Roche Diagnostics Corporation $27,201 0

Top Doctors Receiving Payments for AVENIO Millisect

Doctor Specialty Location Total Records
Unknown San Diego, CA $727,809 11
, MD Radiation Oncology Saint Louis, MO $3,300 3
, MD Medical Microbiology Memphis, TN $2,900 1
, M.D Anatomic Pathology & Clinical Pathology New York, NY $2,900 1
, M.D Specialist Sacramento, CA $2,400 1
, M.D Anatomic Pathology & Clinical Pathology West Hollywood, CA $100.73 1

About AVENIO Millisect

AVENIO Millisect is a device associated with $739,409 in payments to 5 healthcare providers, recorded across 18 transactions in the CMS Open Payments database. The primary manufacturer is ROCHE SEQUENCING SOLUTIONS, INC..

Payment data is available from 2021 to 2023. In 2023, $157,601 was paid across 3 transactions to 1 doctors.

The most common payment nature for AVENIO Millisect is "Unspecified" ($727,809, 98.4% of total).

AVENIO Millisect is associated with 3 research studies, including "RD005888" ($244,601).